OAR 845-025-7110: Cannabinoid Tincture and Capsule Labeling Requirements

Prior to a cannabinoid tincture or capsule being sold or transferred to a consumer, patient, or designated primary caregiver the container holding the tincture or capsule must have a label that has the following information: (1) Processor’s business or trade name, place of address and license number; (2) Business or trade name and place of address of licensee that packaged the product, if different from the processor; (3) Product identity; (4) UID number; (5) Date the product was made; (6) Net weight or volume in U.S. customary and metric units; (7) Serving size and number of servings per container; (8) Amount, in milligrams, of THC and CBD in each serving and in the container; (9) List of all ingredients in descending order of predominance by weight or volume used to process the product; (10) Name of the lab that performed any test and any test analysis date; (11) Universal symbol; (12) Activation time expressed in words or through a pictogram; (13) A statement that reads: “This product is not approved by the FDA to treat, cure, or prevent any disease”; (14) For cannabinoid tinctures and capsules for sale to a consumer, warnings that state: (a) “For use only by adults 21 and older. Keep out of reach of children.” (b) “Do not drive a motor vehicle while under the influence of marijuana.” (c) “BE CAUTIOUS” in bold, capital letters, followed by “Cannabinoid products can take up to 2 hours or more to take effect.” (15) For medical grade cannabinoid tinctures and capsules for use by a patient, the medical grade symbol and medical warnings that state: (a) “For use by OMMP patients only. Keep out of reach of children.” (b) “Do not drive a motor vehicle while under the influence of marijuana.” (c) “BE CAUTIOUS” in bold, capital letters, followed by “Cannabinoid products can take up to 2 hours or more to take effect.”